On 7 February, the Netherlands Enterprise Agency (RVO) opened the application process for its Innovation Credit 2020 scheme. The budget for 2020 is €60 million: €30 million for technical developments and €30 million for clinical development projects. In order to be eligible for Innovation Credit, entrepreneurs must be working on the technical development of a new product or on the clinical development of a medicine or medical aid. The Netherlands Enterprise Agency is keen to fund promising projects in which banks and other investors are reluctant to invest.

All businesses from start-ups to established corporations can benefit from Innovation Credit. The size of the company determines the percentage of credit for which it is eligible. The maximum amount of credit available for clinical developments is €5 million and the maximum amount for technical development projects is €10 million.

Click here for more information on the scheme and how to apply for it.